JP

Jitesh Premjibhai Hinhoriya

Director Director DIN 06545918
DIN 06545918 First appointment Apr 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2013
Shareholding value •••• Premium profile

About Jitesh Premjibhai Hinhoriya

Data last updated:

Jitesh Premjibhai Hinhoriya was a Director at Apex Medichem Private Limited (2013–2021) and Director at Satellite Pharmaceuticals Private Limited (2018–2020). The companies operate in Pharma.

DIN 06545918
Primary Designation Director
Industry Pharma
First Appointment 05 Apr 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apex Medichem Private Limited U24230MH2005PTC152123
Director05 Apr 20132005₹30.17 Cr (FY 2022)Active
Director26 Sep 20181994₹1.74 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apex Medichem Private Limited
Satellite Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jitesh Premjibhai Hinhoriya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitesh Premjibhai Hinhoriya

Jitesh Premjibhai Hinhoriya was first appointed on 05 Apr 2013 as Director at Apex Medichem Private Limited. The most recent appointment on record is 26 Sep 2018 at Satellite Pharmaceuticals Private Limited.

Jitesh Premjibhai Hinhoriya held 2 earlier board appointments: Apex Medichem Private Limited (Director, 05 Apr 2013 to 03 Mar 2021); Satellite Pharmaceuticals Private Limited (Director, 26 Sep 2018 to 31 Oct 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available